Two oral presentations to highlight biomarker, imaging and quality-of-life data from the open-label compensated MASH cirrhosis (F4c) arm of the Phase 3 MAESTRO-NAFLD-1 trial of RezdiffraPoster of ...

AI models outperform traditional rule-based systems in identifying high-risk patients by integrating diverse data sources and ...

Participants were presented with polyphonic music made of two monophonic streams (PolyOrig condition), with control stimuli where the average pi ...

Republicans are eyeing ways to keep illegal immigrants out of the population counts that determine apportionment.

LOS ANGELES - In mid-July of this year, with great fanfare, LAHSA announced the results of the Point in Time Count of the city's homeless that was conducted in late January 2025. They showed an ...

The software includes scattergrams comparing attempted vs achieved corrections, which can be used to refine surgical ...

This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...

Medical practitioners are constantly updating and refining approaches to prostate cancer care, while new cutting-edge ...

Renal Cell Carcinoma (RCC): FDA approved oral Everolimus for advanced RCC after failure of sunitinib and/or sorafenib. Approval was based on RECORD-1 randomized phase III (everolimus 10 mg PO daily vs ...

As the federal and state governments focus their attention on malaria, TB, and HIV control, thousands of Nigerians, including ...

Visa Inc. ( NYSE: V) Q4 2025 Earnings Call October 28, 2025 5:00 PM EDT ...